Project Grant HT94252510865
Award Date 9/1/25
Completion Date 8/31/29
Dollars Obligated $1.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,180,294 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to enhance precision oncology for underserved breast cancer patients through deep learning-aided histopathology analysis. The 3-year project, running from September 1, 2025 to August 31, 2028, aims to develop innovative diagnostic tools and therapeutic approaches...
- The U.S. Defense Health Agency awarded The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a $1,140,766 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The award, effective September 1, 2024 through August 31, 2027, will fund a novel mHealth balance assessment and rehabilitation project using computer vision and AI for patients with neurofibromatosis type 2 (NF2). MGH, as the primary research institution, will...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,234,505 project grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research titled "COTARGETING THE TUMOR MICROENVIRONMENT TO REVOLUTIONIZE ANTIBODY-DRUG CONJUGATE THERAPY FOR REFRACTORY BREAST CANCERS". The award, funded through the Military Medical Research and Development program (CFDA 12.420), aims to transform healthcare for military service members,...
- The Department of Defense's Defense Health Agency awarded a $1,385,292 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), with a performance period from August 15, 2025 to August 14, 2028. The grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Through this award,...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,865,846 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on July 1, 2024. The funding will support the project "TARGETING NEUROIMMUNE AND EPITHELIAL SIGNALING FOR ECZEMA TREATMENT" through June 30, 2028. MGH, a leading academic medical center and research institution, will conduct biomedical research,...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $5,871,932 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a scalable and efficient self-assembling vaccine platform to enable rapid development of U.S. military vaccines. The research scope includes the development of a peptide concatenation technique by the Liu-Xu Lab at Texas A&M University,...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), has been awarded a $1,000,236.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, effective April 1, 2024 through March 31, 2028, will fund research to "UNLOCK THE CTDNA MUTATIONAL PATTERNS FOR EARLY CANCER DETECTION AND NONINVASIVE BIOMARKERS." As a leading academic medical center and research...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $198,000.00 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on "Precision Medicine for Non Small Cell Lung Cancer Brain Metastases: Noninvasive Detection of Targetable Mutations Using Radiosurgery." The award period runs from May 1, 2025 to April 30, 2026. As a renowned academic...
- The federal Project Grant award of $992,302 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), located in Boston, MA. This grant, awarded on September 15, 2025, supports advanced biomedical research aimed at "Targeting MHCII Ubiquitination to Induce Immune Regulation in Vascularized Composite Tissue Transplantation". MGH, a...